These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1249 related articles for article (PubMed ID: 31255487)
1. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Kim S; Kwon SH; Kam TI; Panicker N; Karuppagounder SS; Lee S; Lee JH; Kim WR; Kook M; Foss CA; Shen C; Lee H; Kulkarni S; Pasricha PJ; Lee G; Pomper MG; Dawson VL; Dawson TM; Ko HS Neuron; 2019 Aug; 103(4):627-641.e7. PubMed ID: 31255487 [TBL] [Abstract][Full Text] [Related]
2. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824 [TBL] [Abstract][Full Text] [Related]
3. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
4. Limited spread of pathology within the brainstem of α-synuclein BAC transgenic mice inoculated with preformed fibrils into the gastrointestinal tract. Uemura N; Yagi H; Uemura MT; Yamakado H; Takahashi R Neurosci Lett; 2020 Jan; 716():134651. PubMed ID: 31783082 [TBL] [Abstract][Full Text] [Related]
9. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233 [TBL] [Abstract][Full Text] [Related]
10. Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model. Alwani A; Maziarz K; Burda G; Jankowska-Kiełtyka M; Roman A; Łyszczarz G; Er S; Barut J; Barczyk-Woźnicka O; Pyza E; Kreiner G; Nalepa I; Chmielarz P Pharmacol Rep; 2023 Dec; 75(6):1474-1487. PubMed ID: 37725330 [TBL] [Abstract][Full Text] [Related]
11. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002 [TBL] [Abstract][Full Text] [Related]
12. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology. Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109 [TBL] [Abstract][Full Text] [Related]
13. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195 [TBL] [Abstract][Full Text] [Related]
14. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424 [TBL] [Abstract][Full Text] [Related]
15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice. Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282 [TBL] [Abstract][Full Text] [Related]
16. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095 [TBL] [Abstract][Full Text] [Related]
17. Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Shen Y; Yu WB; Shen B; Dong H; Zhao J; Tang YL; Fan Y; Yang YF; Sun YM; Luo SS; Chen C; Liu FT; Wu JJ; Xiao BG; Yu H; Koprich JB; Huang ZL; Wang J Brain; 2020 Dec; 143(11):3374-3392. PubMed ID: 33170925 [TBL] [Abstract][Full Text] [Related]
18. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils. Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164 [TBL] [Abstract][Full Text] [Related]
19. Intrastriatal injection of Parkinson's disease intestine and vagus lysates initiates α-synucleinopathy in rat brain. Yang Z; Wang Y; Wei M; Li S; Jia C; Cheng C; Al-Nusaif M; Zhang J; Liu C; Le W Cell Death Dis; 2023 Jan; 14(1):4. PubMed ID: 36604420 [TBL] [Abstract][Full Text] [Related]